Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom

NCT02459990 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02459990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02459990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
June 30, 2015
Enrollment
22,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension